Natural Capsules Reports Q2FY27 Results and API Strategy Update
Natural Capsules Ltd · Investor Presentation · 16 Nov 2026, 2:57 am
Natural Capsules Reports Q2FY27 Results and API Strategy Update Natural Capsules reported consolidated revenue from operations of ₹51.15 Cr in Q2FY27, up 12% YoY and 5% QoQ. Consolidated EBITDA rose to ₹3.01 Cr with margins at 5.88%, up 781 bps YoY and 358 bps QoQ, while net loss narrowed to ₹4.22 Cr. Growth was driven by converting idle HPMC lines to gelatin. The company added Mankind Pharma and cleared Zydus Lifesciences' audit. In the API unit, seven COPP filings are underway for completion by Mar'27 alongside 16 planned DMF/CEP filings.
Original exchange filing (PDF)
More announcements from Natural Capsules Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunil Laxminarayana Mundra · 16 Nov 2026
- Please find enclosed herewith Press Release made to Investors and Analysts in connection with Q2 Financials. · 16 Nov 2026
- Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company will hold .... · 19 Nov 2026
- We wish to inform you that due to an inadvertent typographical error in the decimal placement in the Consolidated Segment- Wise Revenue, Results & Capital Employed statement we are submitting .... · 15 Nov 2026
- Approve the Allotment of Securities on Preferential Basis. · 14 Nov 2026
- In order to close the matter and maintain compliance harmony, the company has deposited the requisite fine amount as demanded by the Stock Exchanges. · 14 Nov 2026
- 1. Approved the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter and Half Yearly ended September, 2026. 2. Approved the Allotment of Securities on .... · 14 Nov 2026
- Natural Capsules Limited has informed the Exchange regarding Outcome of Board Meeting held on November 13, 2026. · 14 Nov 2026
